000 01255 a2200349 4500
005 20250515093314.0
264 0 _c20080124
008 200801s 0 0 eng d
022 _a1570-1638
024 7 _a10.2174/157016307782109652
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSampath, Janardhan
245 0 0 _aAlternative splice variants of survivin as potential targets in cancer.
_h[electronic resource]
260 _bCurrent drug discovery technologies
_cOct 2007
300 _a174-91 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlternative Splicing
650 0 4 _aAnimals
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aInhibitor of Apoptosis Proteins
650 0 4 _aMicrotubule-Associated Proteins
_xantagonists & inhibitors
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aOligonucleotides, Antisense
_xgenetics
650 0 4 _aRepressor Proteins
650 0 4 _aSurvivin
700 1 _aPelus, Louis M
773 0 _tCurrent drug discovery technologies
_gvol. 4
_gno. 3
_gp. 174-91
856 4 0 _uhttps://doi.org/10.2174/157016307782109652
_zAvailable from publisher's website
999 _c17503896
_d17503896